Simcere Pharmaceutical Group is a holding company. The Company principally engaged in the research, development, manufacture and distribution of pharmaceutical and vaccine products in the People�s Republic of China. As of December 31, 2011, it manufactured and sold 47 pharmaceutical products and is the distributor of two additional pharmaceutical products that are marketed under its brand names. It markets and sells its products directly or indirectly to approximately 1,106 pharmaceutical distributors who in turn sell these products to other distributors, hospitals and retail pharmacies throughout China. As of March 31, 2012, italso had over 10 product candidates in various stages of development, including treatments for cancer and cardiovascular diseases. It has obtained approvals from the State Food and Drug Administration (SFDA) to manufacture and sell over 223 other products. In December 2011, the Company acquired an additional 9.80% interest in Jilin Boda Pharmaceutical Co., Ltd.